Article
Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis.
The Journal of allergy and clinical immunology - 1 Jun 2013
Sampaio Elizabeth P, Hsu Amy P, Pechacek Joseph, Bax Hannelore I, Dias Dalton L, Paulson Michelle L, Chandrasekaran Prabha, Rosen Lindsey B, Carvalho Daniel S, Ding Li, Vinh Donald C, Browne Sarah K, Datta Shrimati, Milner Joshua D, Kuhns Douglas B, Long Priel Debra A, Sadat Mohammed A, Shiloh Michael, De Marco Brendan, Alvares Michael, Gillman Jason W, Ramarathnam Vivek, de la Morena Maite, Bezrodnik Liliana, Moreira Ileana, Uzel Gulbu, Johnson Daniel, Spalding Christine, Zerbe Christa S, Wiley Henry, Greenberg David E, Hoover Susan E, Rosenzweig Sergio D, Galgiani John N, Holland Steven M
Abstract excerpt
BACKGROUND: Impaired signaling in the IFN-γ/IL-12 pathway causes susceptibility to severe disseminated infections with mycobacteria and dimorphic yeasts. Dominant gain-of-function mutations in signal transducer and activator of transcription 1 (STAT1) have been associated with chronic mucocutaneous candidiasis. OBJECTIVE: We sought to identify the molecular defect in patients with disseminated dimorphic yeast...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
